<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="100">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 22, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02152137</url>
  </required_header>
  <id_info>
    <org_study_id>A091305</org_study_id>
    <secondary_id>U10CA031946</secondary_id>
    <secondary_id>U10CA180821</secondary_id>
    <secondary_id>NCI-2014-00686</secondary_id>
    <nct_id>NCT02152137</nct_id>
  </id_info>
  <brief_title>Efatutazone With Paclitaxel Versus Paclitaxel Alone in Treating Patients With Advanced Anaplastic Thyroid Cancer</brief_title>
  <official_title>A Phase 2 Randomized Study of Efatutazone, an Oral PPAR Agonist, in Combination With Paclitaxel Versus Paclitaxel in Patients With Advanced Anaplastic Thyroid Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alliance for Clinical Trials in Oncology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Daiichi Sankyo Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Alliance for Clinical Trials in Oncology</source>
  <oversight_info>
    <authority>United States: NCI Central Institutional Review Board</authority>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized phase II trial studies how well efatutazone with paclitaxel compared to
      paclitaxel alone works in treating patients with advanced anaplastic thyroid cancer. Drugs
      used in chemotherapy, such as efatutazone and paclitaxel, work in different ways to stop the
      growth of tumor cells, either by killing the cells by stopping them from dividing or by
      stopping them from spreading. It is not yet known whether efatutazone in combination with
      paclitaxel is more effective than paclitaxel alone in treating patients with advanced
      anaplastic thyroid cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a Phase 2 randomized study of efatutazone with paclitaxel compared to paclitaxel
      alone. Patients are randomized to one of two treatment arms, efatutazone in combination with
      paclitaxel or paclitaxel alone. Protocol therapy will consist of continuous cycles
      administered every 21 days. Treatment will continue until disease progression, unacceptable
      adverse events, or a minimum of two cycles beyond a complete response. The primary and
      secondary objectives are listed below.

      Primary objective:

      To determine if the combination of paclitaxel and efatutazone improves overall survival (OS)
      compared to paclitaxel alone in patients with advanced anaplastic thyroid cancer.

      Secondary objective:

      To compare the confirmed response rate, duration of response, progression-free survival
      (PFS), and adverse event rates between the combination of paclitaxel and efatutazone vs.
      paclitaxel alone.

      Patients will be followed for every 6 months until 5 years after registration.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>Up to 5 years post-randomization</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Confirmed response rate</measure>
    <time_frame>Up to 5 years post-randomization</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression Free Survival</measure>
    <time_frame>Up to 5 years post-randomization</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse events, graded according to Common Terminology Criteria for Adverse Events version 4.0</measure>
    <time_frame>Up to 5 years post-randomization</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Anaplastic Thyroid Cancer</condition>
  <condition>Recurrent Thyroid Cancer</condition>
  <arm_group>
    <arm_group_label>efatutazone and paclitaxel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive efatutazone 0.5 mg PO twice daily in combination with paclitaxel 175 mg/m^2 IV day 1 of an every 21 day cycle. Please note that patients receive efatutazone continuously with no break between cycles. Treatment will continue until disease progression, unacceptable adverse events or a minimum of 2 cycles beyond a complete response.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>paclitaxel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive paclitaxel 175 mg/m^2 IV day 1 of an every 21 cycle. Treatment will continue until disease progression, unacceptable adverse events or a minimum of 2 cycles beyond a complete response.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>efatutazone</intervention_name>
    <description>Given PO</description>
    <arm_group_label>efatutazone and paclitaxel</arm_group_label>
    <other_name>CS-7017</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paclitaxel</intervention_name>
    <description>Given IV</description>
    <arm_group_label>efatutazone and paclitaxel</arm_group_label>
    <arm_group_label>paclitaxel</arm_group_label>
    <other_name>Taxol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        1. Documentation of Disease - Patients must have histologically or cytologically
             diagnosed advanced anaplastic thyroid cancer (ATC).

          2. Patients must have measurable disease as defined in the protocol.

          3. Patients must have either metastatic (stage IVC) or locally advanced unresectable
             disease (stage IVB).

          4. Prior Treatment:

               -  Patients should have resolution of any toxic effects of prior therapy (except
                  alopecia) to NCI CTCAE, Version 4.0, grade 1.

               -  There is no limit to the number of prior lines of treatment a patient has
                  received.

               -  No treatment with chemotherapy, radiation therapy, immunotherapy, biological
                  therapy, hormonal therapy, or other thiazolidinediones (TZDs) ≤ 28 days before
                  study registration.

               -  No prior taxane therapy ≤ 6 months, except as a radiosensitizer.

          5. No history of the following:

               -  Class III or IV congestive heart failure (CHF)

               -  Grade 3 or 4 thromboembolic event ≤ 6 months

               -  Pericardial effusion ≤ 12 months (any grade)

               -  Pericardial involvement with tumor

               -  Grade 2 or higher pleural effusion ≤ 6 months

          6. No current symptomatic, untreated, or uncontrolled brain metastases present

          7. No major surgery ≤ 28 days prior to registration

          8. No grade 2 or higher neuropathy

          9. No known history of severe hypersensitivity reactions to any of the components of
             efatutazone or paclitaxel formulations

         10. Not pregnant and not nursing, because this study involves an agent that has known
             genotoxic, mutagenic and teratogenic effects. Therefore, for women of childbearing
             potential only, a negative pregnancy test done ≤ 7 days prior to registration is
             required

         11. Age ≥ 18 years

         12. Concomitant Medications:

               -  Patients with diabetes mellitus requiring concurrent treatment with insulin or
                  thiazolidinedione (TZD) oral agents are not eligible.

               -  Patients with known hypersensitivity to any TZD oral agents are not eligible.

         13. Eastern Cooperative Oncology Group (ECOG) Performance Status ≤ 2

         14. Required Initial Laboratory Values:

               -  Absolute Neutrophil Count (ANC) ≥ 1,500/mm3

               -  Platelet Count ≥ 100,000/mm3

               -  Creatinine ≤ 1.5 x ULN (Upper Limit of Normal) mg/dL OR

               -  Calculated Creatinine Clearance ≥ 60 mL/min

               -  Bilirubin ≤ 1.5 x ULN

               -  Aspartate aminotransferase (AST) ≤ 2.5 x ULN
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Smallridge, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert Smallridge, MD</last_name>
    <phone>904 953-2392</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Smallridge, MD</last_name>
      <phone>904-953-2392</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Francis Hospital and Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beebe Medical Center</name>
      <address>
        <city>Lewes</city>
        <state>Delaware</state>
        <zip>19958</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Grubbs, MD</last_name>
      <phone>302-366-1200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christiana Gynecologic Oncology LLC</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Grubbs, MD</last_name>
      <phone>302-366-1200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Delaware Clinical and Laboratory Physicians PA</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Grubbs, MD</last_name>
      <phone>302-366-1200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helen F Graham Cancer Center</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Grubbs, MD</last_name>
      <phone>302-366-1200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Oncology Hematology Consultants PA</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Grubbs, MD</last_name>
      <phone>302-366-1200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christiana Care Health System-Christiana Hospital</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Grubbs, MD</last_name>
      <phone>302-366-1200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beebe Health Campus</name>
      <address>
        <city>Rehoboth Beach</city>
        <state>Delaware</state>
        <zip>19971</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Grubbs, MD</last_name>
      <phone>302-366-1200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nanticoke Memorial Hospital</name>
      <address>
        <city>Seaford</city>
        <state>Delaware</state>
        <zip>19973</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Grubbs, MD</last_name>
      <phone>302-366-1200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christiana Care Health System-Wilmington Hospital</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Grubbs, MD</last_name>
      <phone>302-366-1200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Smallridge, MD</last_name>
      <phone>904-953-2392</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncare Hawaii Inc. - Pali Momi</name>
      <address>
        <city>Aiea</city>
        <state>Hawaii</state>
        <zip>96701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pali Momi Medical Center</name>
      <address>
        <city>Aiea</city>
        <state>Hawaii</state>
        <zip>96701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncare Hawaii Inc - POB II</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen's Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Straub Clinic and Hospital</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Hawaii Cancer Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuakini Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>OnCare Hawaii - Liliha</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncare Hawaii Inc. - Kuakini</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kapiolani Medical Center for Women and Children</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96826</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wilcox Memorial Hospital and Kauai Medical Clinic</name>
      <address>
        <city>Lihue</city>
        <state>Hawaii</state>
        <zip>96766</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Berenberg, MD</last_name>
      <phone>808-586-2979</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Alphonsus Cancer Care Center-Boise</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83706</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Chanute</name>
      <address>
        <city>Chanute</city>
        <state>Kansas</state>
        <zip>66720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Dodge City</name>
      <address>
        <city>Dodge City</city>
        <state>Kansas</state>
        <zip>67801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - El Dorado</name>
      <address>
        <city>El Dorado</city>
        <state>Kansas</state>
        <zip>67042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Fort Scott</name>
      <address>
        <city>Fort Scott</city>
        <state>Kansas</state>
        <zip>66701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Independence</name>
      <address>
        <city>Independence</city>
        <state>Kansas</state>
        <zip>67301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Kingman</name>
      <address>
        <city>Kingman</city>
        <state>Kansas</state>
        <zip>67068</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lawrence Memorial Hospital</name>
      <address>
        <city>Lawrence</city>
        <state>Kansas</state>
        <zip>66044</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Liberal</name>
      <address>
        <city>Liberal</city>
        <state>Kansas</state>
        <zip>67901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Newton</name>
      <address>
        <city>Newton</city>
        <state>Kansas</state>
        <zip>67114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Parsons</name>
      <address>
        <city>Parsons</city>
        <state>Kansas</state>
        <zip>67357</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Pratt</name>
      <address>
        <city>Pratt</city>
        <state>Kansas</state>
        <zip>67124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Salina</name>
      <address>
        <city>Salina</city>
        <state>Kansas</state>
        <zip>67401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Wellington</name>
      <address>
        <city>Wellington</city>
        <state>Kansas</state>
        <zip>67152</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Associates In Womens Health</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Wichita Medical Arts Tower</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Main Office</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Via Christi Regional Medical Center</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas - Winfield</name>
      <address>
        <city>Winfield</city>
        <state>Kansas</state>
        <zip>67156</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaker Dakhil, MD</last_name>
      <phone>316-262-4467</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Mercy Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oakwood Hospital and Medical Center</name>
      <address>
        <city>Dearborn</city>
        <state>Michigan</state>
        <zip>48124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint John Hospital and Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Genesys Hurley Cancer Institute</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hurley Medical Center</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allegiance Health</name>
      <address>
        <city>Jackson</city>
        <state>Michigan</state>
        <zip>49201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sparrow Hospital</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Mary Mercy Hospital</name>
      <address>
        <city>Livonia</city>
        <state>Michigan</state>
        <zip>48154</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Mercy Oakland</name>
      <address>
        <city>Pontiac</city>
        <state>Michigan</state>
        <zip>48341</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Mercy Port Huron</name>
      <address>
        <city>Port Huron</city>
        <state>Michigan</state>
        <zip>48060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Mary's of Michigan</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint John Macomb-Oakland Hospital</name>
      <address>
        <city>Warren</city>
        <state>Michigan</state>
        <zip>48093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tareq Al Baghdadi, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Smallridge, MD</last_name>
      <phone>904-953-2392</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Care Cancer Center - Carrie J Babb Cancer Center</name>
      <address>
        <city>Bolivar</city>
        <state>Missouri</state>
        <zip>65613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Carlson, MD</last_name>
      <phone>417-820-3554</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Freeman Health System</name>
      <address>
        <city>Joplin</city>
        <state>Missouri</state>
        <zip>64804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Carlson, MD</last_name>
      <phone>417-820-3554</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Phelps County Regional Medical Center</name>
      <address>
        <city>Rolla</city>
        <state>Missouri</state>
        <zip>65401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Carlson, MD</last_name>
      <phone>417-820-3554</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Louis Cancer and Breast Institute - South City</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Carlson, MD</last_name>
      <phone>417-820-3554</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas Adkins, MD</last_name>
      <phone>314-362-5654</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Research for the Ozarks NCORP</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Carlson, MD</last_name>
      <phone>417-820-3554</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cox Health South Hospital</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Carlson, MD</last_name>
      <phone>417-820-3554</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nooshin Hashemi-Sadraei, MD</last_name>
      <phone>513-558-2158</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Pointe</name>
      <address>
        <city>West Chester</city>
        <state>Ohio</state>
        <zip>45069</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nooshin Hashemi-Sadraei, MD</last_name>
      <phone>513-558-2158</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammad Razaq, MD</last_name>
      <phone>405-271-8777</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tulsa Cancer Institute</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74146</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammad Razaq, MD</last_name>
      <phone>405-271-8777</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>August 12, 2015</lastchanged_date>
  <firstreceived_date>May 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thyroid Carcinoma, Anaplastic</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
    <mesh_term>Efatutazone</mesh_term>
    <mesh_term>Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
